Clinical Trial Finds Cannabis Use Not a Barrier to Quitting Nicotine Vaping
A clinical trial found that cannabis use doesn't hinder nicotine vaping cessation with varenicline treatment in young adults.Summary
Researchers at Mass General Brigham conducted a clinical trial involving 261 participants aged 16-25 to investigate the impact of cannabis use on nicotine vaping cessation. The study revealed that varenicline, a medication aiding nicotine quitting, was effective regardless of cannabis use. Participants were divided based on cannabis usage – no use, 1-3 days/week, or 4-7 days/week – but cannabis use did not impede their ability to abstain from nicotine vaping. Varenicline demonstrated higher abstinence rates compared to behavioral support alone, and did not affect cannabis use rates. The findings suggest that cannabis use shouldn't be considered a barrier to vaping cessation treatment and can inform public health messaging.
(Source：Google News)
